DDi recognised as Finalist in "the 2015 Clinical Informatics News Best Practices Award "
Clinical Informatics News Best Practices Awards were announced on February 26, 2015 at the Scope Summit in Orlando. DDi is honoured as Finalist in the 2015 Clinical Informatics News Best Practices award for Clinmetanoia.
- Newark, NJ (1888PressRelease) December 18, 2015 - DDi (Drug Development informatics) is a prominent Technology partner to the Life Sciences industry. Being a IT subsidiary of MakroCare, a world-class drug development services company, DDi has built its solution competency with a unique blend of functional and domain expertise to serve the technology needs of global clients. We provide smarter technology for Clinical Development, Regulatory and Enterprise domains by providing innovative technology products and solutions for the Life Science organizations of various sizes. Our customer base includes organizations from Top 50 global pharma companies to small & mid-size biotechnology, medical device companies as well as academic/ research institutes.
Clinical Informatics News Best Practices Awards were announced on February 26, 2015 at the Summit for Clinical Ops Executives, SCOPE, in Orlando. DDi is honoured as Finalist in "the 2015 Clinical Informatics News Best Practices award." for Clinmetanoia.
'ClinMetanoia' is an innovative clinical intelligence solution that facilitates Real-time decision making, Risk Based monitoring, Oversight / Governance, Central Statistical Monitoring and Key Analytics. This solution shows the results in a collaborative platform as graphical reports, customized dashboards, listing reports with advance visualization. ClinMetanoia helps clients to monitor clinical trials in a much better manner by using pre-defined statistical models like risk analysis, time series, outliers, multivariate analysis.Few of the top pharmaceutical companies are using DDi's Clinical Analytic Solution 'ClinMetanoia.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam